This is a type of bone cancer that usually affects children and young adults, often before the age of 20. It starts in the bone marrow, the soft tissue inside bones. It's called Ewing Sarcoma after the doctor who first described it.
Every report comes from a Lived member, sent anonymously.
Have you tried Adriamycin (Doxorubicin) for Ewing Sarcoma?
Ewing sarcoma is a rare cancer that most often starts in a bone, though it can also start in the soft tissues that connect and support the body, such as muscle. It is most common in teenagers and young adults, but it also occurs in younger children and in adults, mainly in their 20s and 30s. In the United States, about 200 children and teens are diagnosed each year. The tumor often grows in the pelvis, the long bones of the legs or arms, the ribs or the spine. The usual first sign is pain and swelling near the tumor, sometimes with a lump that can feel soft and warm. Some people also have fever without a clear cause, tiredness, weight loss, a limp, or a bone that breaks after little or no injury. Because ongoing bone pain in an active young person is easy to put down to sports or growing, diagnosis is often delayed by a few months. Ewing sarcoma matters because it can spread, most often to the lungs, other bones and the bone marrow. It is also very treatable: most people whose cancer has not spread are treated with the aim of cure.
Ewing sarcoma is driven by a change inside the tumor cells in which two genes become abnormally joined. In most cases, part of a gene called EWSR1 fuses with part of another gene, creating an abnormal signal that pushes cells to grow and divide. This change develops in the tumor itself. It is not usually inherited and is not passed on to children. What triggers that change is not known, and it may simply be a random event in a cell. There are no known lifestyle or environmental causes, so nothing a person or parent did or did not do is known to bring it on, and there is no known way to prevent it. Ewing sarcoma is more common in males and in White people, and it is very rare in Black people. Inherited risk appears uncommon, although children with Fanconi anemia, an inherited bone marrow disorder, may be at increased risk.
Evaluation usually starts with an X-ray of the painful area, followed by an MRI (magnetic resonance imaging) scan to show the tumor's size and how far it extends into nearby tissue. A biopsy, in which a sample of the tumor is removed with a needle or through a small incision, is the only way to confirm the diagnosis. Where the biopsy is taken matters. A poorly placed biopsy can make later surgery or radiation more extensive, so it is best planned with the surgeon and team who will treat the cancer, ideally at a center experienced with sarcomas. The tissue is examined under a microscope and tested for the characteristic gene fusion. Genetic testing also separates Ewing sarcoma from rarer look-alike tumors, called undifferentiated small round cell sarcomas, which are usually treated in a similar way. Once Ewing sarcoma is confirmed, staging tests show whether it has spread. These usually include a CT (computed tomography) scan of the chest to look at the lungs, and a PET-CT scan (positron emission tomography combined with CT, which highlights active cancer cells) or a bone scan to look at the rest of the skeleton. Blood tests include a level called LDH (lactate dehydrogenase); a high level before treatment is linked to a larger tumor and a less favorable outlook. A bone marrow biopsy is done if other tests suggest spread. The result is described as localized (confined to where it began and nearby tissue), metastatic (spread to distant sites) or, after treatment, recurrent.
Treatment combines medicine that works throughout the body with treatment aimed at the tumor itself, and it is planned by a team that typically includes cancer specialists, surgeons, radiation oncologists, rehabilitation staff and psychosocial support. Chemotherapy usually comes first. Several drugs are given in alternating cycles, and in the United States the standard combines vincristine, doxorubicin and cyclophosphamide alternating with ifosfamide and etoposide. Giving cycles every two weeks rather than every three improved results in a large trial without adding side effects. Treatment generally lasts about 6 to 12 months in total. Chemotherapy shrinks the main tumor and targets cancer cells that may already have spread but are too small to see. It commonly causes hair loss, nausea and low blood counts that raise the risk of infection, so frequent blood tests and hospital visits are part of the process. After the first cycles, the main tumor is treated with surgery, radiation or both, which doctors call local control. Surgery aims to remove the whole tumor; removed bone may be replaced with a bone graft or a metal implant, and when the tumor is in an arm or leg, surgery that saves the limb is sometimes possible. Radiation is used when the tumor cannot be removed safely or when surgery would cost too much function or appearance, and it may be added when cancer cells remain after surgery. The choice weighs how completely the tumor can be removed against the long-term effects of radiation, which include a small risk of a later cancer in the treated area. When the cancer has spread, the same treatments are used, often with radiation to the lungs or other sites of spread. For cancer that returns, other chemotherapy combinations, radiation, surgery and sometimes high-dose chemotherapy followed by a return of the person's own stored stem cells may be used, and clinical trials are an important option. Some of these treatments can affect fertility. Talking with a fertility specialist before treatment starts allows time to consider options such as storing sperm or eggs.
The outlook depends most on whether the cancer has spread when it is found. About a quarter of people have spread at diagnosis. With current treatment, about 70% of people with localized Ewing sarcoma are alive and free of cancer five years later. For those whose cancer has already spread, long-term survival is about 30% overall, with better results when spread is limited to the lungs than when it involves bone or bone marrow. Tumors in the hands, feet and lower arms or legs tend to do better than those in the pelvis or trunk, and a good response to initial chemotherapy is a favorable sign. These are averages from groups of patients and cannot predict one person's course. The treatment year is demanding. Chemotherapy cycles, hospital stays for fever or low blood counts, surgery and rehabilitation can interrupt school, work and social life. After limb surgery, physical therapy is a central part of regaining strength and walking. Support from social workers, psychologists and school or workplace accommodations can make this period more manageable. After treatment ends, regular check-ups with scans continue for years, because the cancer can come back after treatment. Survivors also need long-term follow-up for late effects that can appear months or years later, including heart effects from doxorubicin, effects on growth, fertility, kidney function, thinking and mood, and a small risk of a second cancer, such as a type of leukemia or a sarcoma in an area that received radiation.
See a doctor about bone or joint pain that keeps coming back or does not ease over a few weeks, or for swelling or a lump in an arm, leg, the chest or the pelvis, a limp, or a bone that breaks after a minor injury. Ask for an X-ray if pain persists, rather than assuming it is a sports strain or growing pains. Seek same-day medical care for back pain together with new weakness, numbness or loss of movement in the arms or legs, which can mean a tumor is pressing on the spinal cord or nerves. During chemotherapy, follow the care team's instructions for fever, because low blood counts make infections serious. After treatment, report new or returning pain, swelling, a persistent cough or shortness of breath at the next opportunity rather than waiting for a scheduled visit.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Ewing Sarcoma is like, what's helped you, or ask the community a question.